Back

Benefit of optimal medical therapy in patients with polyvascular disease undergoing drug-eluting stent implantation

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - PCI - Adjunctive drug therapy PCI - Adjunctive drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Raisuke Iijima

Toho University, Tokyo (Japan)

13 More presentations in this session

Presentation thumbnail
Associate Professor B. Zheng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor S. Cornara (Savona, IT)
Abstract Slides
Presentation thumbnail
Doctor C. Cheung (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Professor Y. Lopatin (Volgograd, RU)
Abstract
Presentation thumbnail
Doctor C. Chen (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - PCI - Adjunctive drug therapy

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOME
31 August 2020
thumbnail
Congress Presentation
Is there a benefit of complete revascularization in all acute coronary syndromes and in all forms of revascularization?
21 May 2023
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources